488 related articles for article (PubMed ID: 12971801)
1. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
[TBL] [Abstract][Full Text] [Related]
2. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo.
Fu PP; Chou MW; Churchwell M; Wang Y; Zhao Y; Xia Q; Gamboa da Costa G; Marques MM; Beland FA; Doerge DR
Chem Res Toxicol; 2010 Mar; 23(3):637-52. PubMed ID: 20078085
[TBL] [Abstract][Full Text] [Related]
4. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
Xia Q; Yan J; Chou MW; Fu PP
Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
Yan J; Xia Q; Chou MW; Fu PP
Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
Wang YP; Yan J; Beger RD; Fu PP; Chou MW
Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
[TBL] [Abstract][Full Text] [Related]
7. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
[TBL] [Abstract][Full Text] [Related]
8. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine.
Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP
Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
[TBL] [Abstract][Full Text] [Related]
10. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation.
Zhao Y; Xia Q; Gamboa da Costa G; Yu H; Cai L; Fu PP
Chem Res Toxicol; 2012 Sep; 25(9):1985-96. PubMed ID: 22857713
[TBL] [Abstract][Full Text] [Related]
11. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
Wang YP; Fu PP; Chou MW
Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
[TBL] [Abstract][Full Text] [Related]
13. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
He X; Xia Q; Ma L; Fu PP
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo.
Yang YC; Yan J; Doerge DR; Chan PC; Fu PP; Chou MW
Chem Res Toxicol; 2001 Jan; 14(1):101-9. PubMed ID: 11170513
[TBL] [Abstract][Full Text] [Related]
15. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
Xia Q; He X; Ma L; Chen S; Fu PP
Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
[TBL] [Abstract][Full Text] [Related]
17. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin.
Zhao Y; Wang S; Xia Q; Gamboa da Costa G; Doerge DR; Cai L; Fu PP
Chem Res Toxicol; 2014 Oct; 27(10):1720-31. PubMed ID: 25211425
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
[TBL] [Abstract][Full Text] [Related]
19. Development of a (32)P-postlabeling/HPLC method for detection of dehydroretronecine-derived DNA adducts in vivo and in vitro.
Yang Y; Yan J; Churchwell M; Beger R; Chan P; Doerge DR; Fu PP; Chou MW
Chem Res Toxicol; 2001 Jan; 14(1):91-100. PubMed ID: 11170512
[TBL] [Abstract][Full Text] [Related]
20. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
